Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Moore

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|November 1, 1974
Potential antitumor agents. 10. Synthesis and biochemical properties of 5-N-alkylamino-,N,N-dialkylamino-, and N-alkylacetamido-1-formylisoquinoline thiosemicarbazonesP D Mooney, B A Booth, E C Moore, et al.
Acta Paediatrica Scandinavica|May 1, 1979
Regional deficiency of secretory IgA in a patient with combined immunodeficiency of the ADA deficient typeE C Moore, R J Laffin, T Tomasi, et al.
The Journal of Investigative Dermatology|July 17, 1998
Aberrant integrin (CR4; alpha(x)beta2; CD11c/CD18) oscillations on neutrophils in a mild form of pyoderma gangrenosumS Shaya, A L Kindzelskii, J Minor, et al.
Advances in Biology of Skin|January 1, 1972
Studies on the mechanism of action of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazonesA C Sartorelli, J Hilton, B A Booth, et al.
Biochemical Pharmacology|October 15, 1982
Aspartate carbamoyltransferase activity, drug concentrations, and pyrimidine nucleotides in tissue from patients treated with N-(phosphonacetyl)-L-aspartateE C Moore, J Friedman, M Valdivieso, et al.
The Journal of Investigative Dermatology|August 12, 1998
Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosumY Adachi, A L Kindzelskii, G Cookingham, et al.
Cancer Research|June 1, 1977
4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone seriesK C Agrawal, J B Schenkman, H Denk, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 7, 2000
Influence of pre-adolescent diet on quantitative ultrasound measurements of the calcaneus in young adult womenM C Wang, E C Moore, P B Crawford, et al.
Biochemical Pharmacology|August 15, 1986
Biochemical pharmacology of N-acetyl-N-(methylcarbamoyloxy)-N'-methylurea (caracemide; NSC-253272)R A Newman, D Farquhar, K Lu, et al.
Cancer Treatment Reports|February 1, 1980
Phase I clinical study of N-(phosphonacetyl)-L-aspartic acid (PALA)M Valdivieso, E C Moore, A M Burgess, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|November 1, 1974
Potential antitumor agents. 10. Synthesis and biochemical properties of 5-N-alkylamino-,N,N-dialkylamino-, and N-alkylacetamido-1-formylisoquinoline thiosemicarbazonesP D Mooney, B A Booth, E C Moore, et al.
Acta Paediatrica Scandinavica|May 1, 1979
Regional deficiency of secretory IgA in a patient with combined immunodeficiency of the ADA deficient typeE C Moore, R J Laffin, T Tomasi, et al.
The Journal of Investigative Dermatology|July 17, 1998
Aberrant integrin (CR4; alpha(x)beta2; CD11c/CD18) oscillations on neutrophils in a mild form of pyoderma gangrenosumS Shaya, A L Kindzelskii, J Minor, et al.
Advances in Biology of Skin|January 1, 1972
Studies on the mechanism of action of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazonesA C Sartorelli, J Hilton, B A Booth, et al.
Biochemical Pharmacology|October 15, 1982
Aspartate carbamoyltransferase activity, drug concentrations, and pyrimidine nucleotides in tissue from patients treated with N-(phosphonacetyl)-L-aspartateE C Moore, J Friedman, M Valdivieso, et al.
The Journal of Investigative Dermatology|August 12, 1998
Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosumY Adachi, A L Kindzelskii, G Cookingham, et al.
Cancer Research|June 1, 1977
4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone seriesK C Agrawal, J B Schenkman, H Denk, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 7, 2000
Influence of pre-adolescent diet on quantitative ultrasound measurements of the calcaneus in young adult womenM C Wang, E C Moore, P B Crawford, et al.
Biochemical Pharmacology|August 15, 1986
Biochemical pharmacology of N-acetyl-N-(methylcarbamoyloxy)-N'-methylurea (caracemide; NSC-253272)R A Newman, D Farquhar, K Lu, et al.
Cancer Treatment Reports|February 1, 1980
Phase I clinical study of N-(phosphonacetyl)-L-aspartic acid (PALA)M Valdivieso, E C Moore, A M Burgess, et al.
Pageof 7